Testing of antibodies to several other autoantigens including CENP-A, PLA2R, and LGI1 that are found in patients with systemic sclerosis, membranous nephropathy, and limbic encephalitis, respectively, revealed little or no autoantibodies in any of COVID-19 adults (data not shown). This evidence concerns the gene CENPA and COVID-19.